1 insiders reported 5 Form 4 transactions for Carisma Therapeutics Inc. (CARM) over the past 18 months (most recent 2025-10-08). Recent activity: Klichinsky Michael (Chief Scientific Officer) Buy 56,982 shares, Klichinsky Michael (Chief Scientific Officer) Sell 56,982 shares, Klichinsky Michael (Chief Scientific Officer) Sell 165,000 shares, Klichinsky Michael (Chief Scientific Officer) Sell 200,000 shares, Klichinsky Michael (Chief Scientific Officer) Sell 119,347 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-08 | Klichinsky Michael | Chief Scientific Officer | Buy | 56,982 | $6,268 |
| 2025-10-08 | Klichinsky Michael | Chief Scientific Officer | Sell | 56,982 | $14,246 |
| 2025-10-03 | Klichinsky Michael | Chief Scientific Officer | Sell | 165,000 | $42,900 |
| 2025-10-03 | Klichinsky Michael | Chief Scientific Officer | Sell | 200,000 | $50,000 |
| 2025-10-03 | Klichinsky Michael | Chief Scientific Officer | Sell | 119,347 | $31,030 |
Source: SEC Form 4 filings · as of 2025-10-08
